These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 23079391)

  • 1. [Proton pump inhibitors in gastro-oesophageal reflux disease: what is the further step?].
    Simon M; Zerbib F
    Presse Med; 2013; 42(7-8):1081-4. PubMed ID: 23079391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors.
    Katz PO; Anderson C; Khoury R; Castell DO
    Aliment Pharmacol Ther; 1998 Dec; 12(12):1231-4. PubMed ID: 9882031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of gastro-oesophageal reflux disease symptoms that do not respond to proton pump inhibitors.
    Woodland P; Sifrim D
    Curr Opin Gastroenterol; 2013 Jul; 29(4):431-6. PubMed ID: 23549342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease?
    Vakil N
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():64-9. PubMed ID: 16042661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent gastro-oesophageal reflux symptoms despite proton pump inhibitor therapy.
    Ang D; How CH; Ang TL
    Singapore Med J; 2016 Oct; 57(10):546-551. PubMed ID: 27779277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors.
    Sifrim D; Zerbib F
    Gut; 2012 Sep; 61(9):1340-54. PubMed ID: 22684483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease.
    Gunaratnam NT; Jessup TP; Inadomi J; Lascewski DP
    Aliment Pharmacol Ther; 2006 May; 23(10):1473-7. PubMed ID: 16669962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: alternative approaches to the long-term management of GERD.
    Fennerty MB
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():39-44. PubMed ID: 16303036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease.
    Katz PO; Tutuian R
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):371-84. PubMed ID: 11403533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical treatment of gastro-oesophageal reflux disease.
    De Giorgi F; Savarese MF; Atteo E; Leone CA; Cuomo R
    Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):276-80. PubMed ID: 17345932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of heartburn not responding to proton pump inhibitors.
    Fass R; Sifrim D
    Gut; 2009 Feb; 58(2):295-309. PubMed ID: 19136523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review: Is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease?
    Lee TJ; Fennerty MB; Howden CW
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1241-51. PubMed ID: 15606386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastro-oesophageal reflux. Physiological or pathological?
    Marchetti F; Tornese G; Ventura A
    BMJ; 2010 Sep; 341():c5155. PubMed ID: 20861110
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care.
    Aanen MC; Weusten BL; Numans ME; de Wit NJ; Baron A; Smout AJ
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1377-84. PubMed ID: 17059519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose or standard-dose proton pump inhibitors for maintenance therapy of gastro-oesophageal reflux disease: a cost-effectiveness analysis.
    You JH; Lee AC; Wong SC; Chan FK
    Aliment Pharmacol Ther; 2003 Mar; 17(6):785-92. PubMed ID: 12641500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic work-up of GERD.
    Vela MF
    Gastrointest Endosc Clin N Am; 2014 Oct; 24(4):655-66. PubMed ID: 25216910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of reflux-related symptoms.
    Dutta U; Moayyedi P
    Best Pract Res Clin Gastroenterol; 2013 Jun; 27(3):387-400. PubMed ID: 23998977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.